Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending
Biologics
Clinical Development
Fierce 50
Special Report
Awards Gala
Awards
CRO Awards
Innovation Awards
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Trending
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending
Biologics
Clinical Development
Fierce 50
Special Report
Awards Gala
Awards
CRO Awards
Innovation Awards
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Melinta Therapeutics
Biotech
Cidara wins near-unanimous AdComm support despite data doubts
Cidara overcame the uncertainties raised by the FDA’s advisory committee to receive near-unanimous backing for its antifungal drug.
Nick Paul Taylor
Jan 25, 2023 10:17am
Melinta pays Cidara $30M for antifungal pending FDA review
Jul 27, 2022 11:05am
Melinta wins bidding war to land deal to acquire Tetraphase
Jun 5, 2020 9:00am
Melinta seeks buyout bids to secure escape from bankruptcy
Feb 14, 2020 8:28am
Melinta files for bankruptcy in another dark day for antibiotics
Jan 2, 2020 8:45am
Melinta CEO Johnson exits amid 'changing circumstances'
Aug 9, 2019 11:00am
